Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 9c/Share

Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $940 thousand.

For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cloudflare Inc. (NET) PT Raised to $330 at Citizens on Infrastructure Subsector Strength
• Goeasy Ltd (GSY:CN) (EHMEF) PT Raised to Cdn$45 at Raymond James
• AMC Entertainment (AMC) Tops Q2 EPS by 16c